December 12, 2025 Posted by: Categories: No Comments The European Medicines Agency (EMA) published updated information on a series of medicines: Lyfnua | European Medicines Agency (EMA) Eucreas | European Medicines Agency (EMA) Scemblix | European Medicines Agency (EMA) Eviplera | European Medicines Agency (EMA) Dacogen | European Medicines Agency (EMA) Pandemic influenza vaccine H5N1 AstraZeneca (previously Pandemic influenza vaccine H5N1 Medimmune) | European Medicines Agency (EMA) Esbriet | European Medicines Agency (EMA) Kovaltry | European Medicines Agency (EMA) Aimovig | European Medicines Agency (EMA) Pifeltro | European Medicines Agency (EMA)
